Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial. [electronic resource] by
- Waters, Cheryl H
- Nausieda, Paul
- Dzyak, Lyudmila
- Spiegel, Joerg
- Rudzinska, Monika
- Silver, Dee E
- Tsurkalenko, Elena S
- Kell, Sherron
- Hsu, Ann
- Khanna, Sarita
- Gupta, Suneel
Producer: 20160613
In:
CNS drugs vol. 29
Availability: No items available.
|
|
8.
|
Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy. [electronic resource] by
- Espay, Alberto J
- Pagan, Fernando L
- Walter, Benjamin L
- Morgan, John C
- Elmer, Lawrence W
- Waters, Cheryl H
- Agarwal, Pinky
- Dhall, Rohit
- Ondo, William G
- Klos, Kevin J
- Silver, Dee E
Publication details: Neurology. Clinical practice Feb 2017
In:
Neurology. Clinical practice vol. 7
Availability: No items available.
|
|
9.
|
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects. [electronic resource] by
- Lyons, Kelly E
- Friedman, Joseph H
- Hermanowicz, Neal
- Isaacson, Stuart H
- Hauser, Robert A
- Hersh, Bonnie P
- Silver, Dee E
- Tetrud, James W
- Elmer, Lawrence W
- Parashos, Sotirios A
- Struck, Lynn K
- Lew, Mark F
- Pahwa, Rajesh
Producer: 20100412
In:
Clinical neuropharmacology vol. 33
Availability: No items available.
|